33 related articles for article (PubMed ID: 27266667)
1. Influence of STR-324, a Dual Enkephalinase Inhibitor, on Postoperative Pain Scores: A Proof-of-Concept Trial in Patients after Laparoscopic Surgery.
van Dasselaar T; van der Wal I; van Velzen M; Juarez-Perez V; Sitbon P; Dahan A
Anesthesiology; 2024 Mar; 140(3):632-633. PubMed ID: 38349755
[No Abstract] [Full Text] [Related]
2. Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase.
Singh R; Jiang R; Williams J; Dobariya P; Hanak F; Xie J; Rothwell PE; Vince R; More SS
bioRxiv; 2024 Apr; ():. PubMed ID: 38617237
[TBL] [Abstract][Full Text] [Related]
3. Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review.
Wang A; Murphy J; Shteynman L; Daksla N; Gupta A; Bergese S
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256863
[TBL] [Abstract][Full Text] [Related]
4. Targeting sensory neuron GPCRs for peripheral neuropathic pain.
Uniyal A; Tiwari V; Tsukamoto T; Dong X; Guan Y; Raja SN
Trends Pharmacol Sci; 2023 Dec; 44(12):1009-1027. PubMed ID: 37977131
[TBL] [Abstract][Full Text] [Related]
5. Origins and Neurochemical Characteristics of Porcine Intervertebral Disc Sympathetic Innervation: a Preliminary Report.
Barczewska M; Juranek J; Wojtkiewicz J
J Mol Neurosci; 2017 Sep; 63(1):50-57. PubMed ID: 28762133
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Delta-Opioid Receptors to Pathophysiological Events Explored by Endogenous Enkephalins.
Roques BP
Handb Exp Pharmacol; 2018; 247():53-70. PubMed ID: 27417433
[TBL] [Abstract][Full Text] [Related]
7. Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs).
Raffa RB; Pergolizzi JV; Taylor R; Ossipov MH;
J Clin Pharm Ther; 2018 Aug; 43(4):443-449. PubMed ID: 29722031
[TBL] [Abstract][Full Text] [Related]
8. Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.
Bonnard E; Poras H; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 2016 Oct; 788():176-182. PubMed ID: 27266667
[TBL] [Abstract][Full Text] [Related]
9. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.
González-Rodríguez S; Poras H; Menéndez L; Lastra A; Ouimet T; Fournié-Zaluski MC; Roques BP; Baamonde A
Scand J Pain; 2017 Jan; 14():25-38. PubMed ID: 28850427
[TBL] [Abstract][Full Text] [Related]
10. Dual enkephalinase inhibitor PL265: a novel topical treatment to alleviate corneal pain and inflammation.
Reaux-Le Goazigo A; Poras H; Ben-Dhaou C; Ouimet T; Baudouin C; Wurm M; Melik Parsadaniantz S
Pain; 2019 Feb; 160(2):307-321. PubMed ID: 30412056
[TBL] [Abstract][Full Text] [Related]
11. New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment.
Poras H; Bonnard E; Dangé E; Fournié-Zaluski MC; Roques BP
J Med Chem; 2014 Jul; 57(13):5748-63. PubMed ID: 24927250
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.
Bonnard E; Poras H; Nadal X; Maldonado R; Fournié-Zaluski MC; Roques BP
Pharmacol Res Perspect; 2015 Mar; 3(2):e00116. PubMed ID: 25692029
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
